World's 2nd Richest Man Is About To Shock The World
Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry...
See what Elon is up to now.

SCPH Insider Trading (scPharmaceuticals)

Insider Ownership Percentage: 4.08%
Insider Buying (Last 12 Months): $4,999,994.10
Insider Selling (Last 12 Months): $0.00

scPharmaceuticals Insider Trading History Chart

scPharmaceuticals Share Price & Price History

▲ +0.2 (2.71%)
As of 03/1/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click to see what happened

scPharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2020Andrew J SchwabMajor ShareholderBuy578,034$8.65$4,999,994.10  
2/14/2020Ra Capital Management, L.P.Major ShareholderBuy271,993$8.20$2,230,342.60  
12/13/2019John H TuckerCEOBuy5,000$5.24$26,200.005,000  
4/11/2019Ra Capital Healthcare Fund LpMajor ShareholderBuy389,862$2.70$1,052,627.40  
See Full Table

SEC Filings (Institutional Ownership Changes) for scPharmaceuticals (NASDAQ:SCPH)

62.53% of scPharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

scPharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/25/2021Dimensional Fund Advisors LP46,878$0.25M0.0%+6.0%0.172%
2/24/2021Virtu Financial LLC36,378$0.19M0.0%N/A0.133%
2/24/2021Alyeska Investment Group L.P.355,690$1.88M0.0%-0.8%1.302%
2/19/2021JPMorgan Chase & Co.18,759$99K0.0%+268.4%0.069%
2/17/2021Worth Venture Partners LLC162,875$0.86M0.7%-7.2%0.596%
2/16/2021Zacks Investment Management38,539$0.20M0.0%N/A0.141%
2/16/2021Alyeska Investment Group L.P.355,690$1.88M0.0%-0.8%1.302%
2/12/2021Ikarian Capital LLC1,466,147$7.76M0.3%-1.0%5.366%
2/11/2021Northern Trust Corp139,357$0.74M0.0%-4.5%0.510%
2/10/2021Renaissance Technologies LLC247,086$1.31M0.0%-17.1%0.904%
2/9/2021Wells Fargo & Company MN19,980$0.11M0.0%+23.0%0.073%
2/9/2021Bank of New York Mellon Corp47,077$0.25M0.0%+226.1%0.172%
2/5/2021BlackRock Inc.322,303$1.71M0.0%+24.2%1.180%
11/17/2020Old Well Partners LLC14,666$0.11M0.1%N/A0.054%
11/16/2020Squarepoint Ops LLC10,264$76K0.0%-71.5%0.038%
11/13/2020Morgan Stanley32,703$0.24M0.0%-14.6%0.120%
11/12/2020JPMorgan Chase & Co.5,092$39K0.0%+181.6%0.019%
11/9/2020Acadian Asset Management LLC9,547$72K0.0%-35.3%0.035%
11/6/2020BlackRock Inc.259,476$1.93M0.0%+0.4%0.950%
11/6/2020Trexquant Investment LP11,087$83K0.0%-57.3%0.041%
11/5/2020New York State Common Retirement Fund6,900$51K0.0%-46.9%0.025%
11/5/2020First Trust Advisors LP23,489$0.18M0.0%N/A0.086%
8/31/2020Bridgeway Capital Management Inc.39,200$0.29M0.0%-38.9%0.143%
8/25/2020Nuveen Asset Management LLC32,739$0.24M0.0%N/A0.120%
8/20/2020Charles Schwab Investment Management Inc.18,959$0.14M0.0%N/A0.090%
8/14/2020Orbimed Advisors LLC4,797,148$35.31M0.5%+40.7%22.833%
8/14/2020Worth Venture Partners LLC175,526$1.29M0.6%+22.2%0.835%
8/14/2020Alyeska Investment Group L.P.388,603$2.86M0.0%N/A1.850%
8/14/2020Sabby Management LLC125,752$0.93M0.2%N/A0.599%
8/14/2020Driehaus Capital Management LLC747,989$5.51M0.1%N/A3.560%
8/14/2020Ikarian Capital LLC1,468,647$10.81M0.9%+36.8%6.990%
8/12/2020Goldman Sachs Group Inc.19,012$0.14M0.0%+10.9%0.090%
8/12/2020Bank of New York Mellon Corp14,438$0.11M0.0%N/A0.069%
8/7/2020Trexquant Investment LP25,973$0.19M0.0%+55.7%0.124%
8/7/2020New York State Common Retirement Fund13,000$96K0.0%N/A0.062%
8/5/20205AM Venture Management LLC3,831,474$28.20M6.2%+17.8%18.236%
7/28/2020Matisse Capital17,685$0.13M0.0%-36.1%0.084%
5/15/2020RA Capital Management L.P.3,518,998$26.04M0.8%+8.4%16.749%
5/15/2020Squarepoint Ops LLC21,802$0.16M0.0%-60.2%0.104%
5/15/2020Morgan Stanley40,502$0.30M0.0%-9.7%0.193%
5/15/2020Ikarian Capital LLC1,073,647$7.95M0.6%N/A5.117%
5/12/2020JPMorgan Chase & Co.41,172$0.31M0.0%+6.0%0.196%
5/11/2020Acadian Asset Management LLC10,347$76K0.0%+16.5%0.049%
5/11/2020Alambic Investment Management L.P.41,523$0.31M0.7%-18.6%0.198%
5/8/2020Trexquant Investment LP16,680$0.12M0.0%N/A0.080%
5/7/2020Matisse Capital27,685$0.21M0.1%+88.5%0.132%
2/20/2020Geode Capital Management LLC31,028$0.18M0.0%-5.1%0.167%
2/14/2020Jacobs Levy Equity Management Inc.17,791$0.10M0.0%+21.6%0.095%
2/13/2020Renaissance Technologies LLC163,677$0.93M0.0%+46.0%0.878%
2/12/2020Alambic Investment Management L.P.51,023$0.29M0.2%-8.6%0.274%
2/5/20205AM Venture Management LLC3,253,440$18.41M4.0%N/A17.460%
10/28/2019Matisse Capital14,685$86K0.1%N/A0.079%
8/14/2019Morgan Stanley13,633$43K0.0%+32.0%0.073%
8/14/2019Paloma Partners Management Co30,000$96K0.0%N/A0.161%
8/14/2019Vanguard Group Inc.88,961$0.28M0.0%-44.6%0.479%
8/13/2019Jacobs Levy Equity Management Inc.36,921$0.12M0.0%+55.8%0.199%
8/13/2019Eversept Partners LP174,297$0.56M0.2%N/A0.938%
8/13/2019BlackRock Inc.18,580$60K0.0%-94.6%0.100%
8/13/2019Parametric Portfolio Associates LLC11,544$37K0.0%-37.0%0.062%
8/13/2019Alambic Investment Management L.P.59,847$0.19M0.1%N/A0.322%
8/13/2019Northern Trust Corp66,570$0.21M0.0%-3.0%0.358%
6/30/2019SG Americas Securities LLC12,877$41K0.0%-24.2%0.069%
4/29/2019SG Americas Securities LLC16,993$51K0.0%N/A0.091%
4/1/2019Deutsche Bank AG8,993$33K0.0%-35.2%0.048%
2/8/2019BlackRock Inc.358,243$1.35M0.0%+2.0%1.929%
12/13/2018Vanguard Group Inc205,919$1.21M0.0%-1.6%1.109%
11/9/2018AWM Investment Company Inc.469,799$2.76M0.5%+15.8%2.530%
11/7/2018JPMorgan Chase & Co.22,664$0.13M0.0%+1,268.6%0.122%
9/18/2018Northern Trust Corp67,932$0.38M0.0%+41.6%0.366%
8/15/2018Colony Group LLC23,209$0.13M0.0%N/A0.125%
8/9/2018BlackRock Inc.348,086$1.97M0.0%+20.7%1.877%
7/24/2018Acadian Asset Management LLC29,815$0.17M0.0%N/A0.161%
5/15/2018California State Teachers Retirement System11,225$0.14M0.0%N/A0.061%
5/15/2018DAFNA Capital Management LLC55,844$0.69M0.3%-43.1%0.301%
5/11/2018Citigroup Inc.38,787$0.48M0.0%N/A0.209%
5/9/2018BlackRock Inc.288,469$3.58M0.0%+21,048.8%1.556%
5/9/2018Northern Trust Corp47,985$0.60M0.0%N/A0.259%
5/7/2018Schwab Charles Investment Management Inc.13,400$0.17M0.0%N/A0.072%
2/15/2018Millennium Management LLC38,182$0.46M0.0%N/A0.217%
2/14/2018Bain Capital Public Equity Management LLC106,794$1.29M0.1%N/A0.606%
2/14/2018Goldman Sachs Group Inc.54,032$0.65M0.0%N/A0.307%
2/14/2018Nicholas Investment Partners LP124,074$1.50M0.1%N/A0.705%
2/13/2018AWM Investment Company Inc.165,100$2M0.4%N/A0.938%
2/10/2018Monashee Investment Management LLC19,000$0.23M0.1%N/A0.108%
2/9/2018Bank of New York Mellon Corp34,269$0.41M0.0%N/A0.195%
Data available starting January 2016

See Full Table
scPharmaceuticals logo
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $7.58

50 Day Range

MA: $6.83

52 Week Range

Now: $7.58


53,659 shs

Average Volume

104,876 shs

Market Capitalization

$207.09 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of scPharmaceuticals?

scPharmaceuticals' top insider investors include:
  1. John H Tucker (CEO)
  2. Andrew J Schwab (Major Shareholder)
  3. Ra Capital Healthcare Fund Lp (Major Shareholder)
  4. Ra Capital Management, LP (Major Shareholder)

Who are the major institutional investors of scPharmaceuticals?

scPharmaceuticals' top institutional investors include:
  1. Ikarian Capital LLC — 5.37%
  2. Alyeska Investment Group L.P. — 1.30%
  3. Alyeska Investment Group L.P. — 1.30%
  4. BlackRock Inc. — 1.18%
  5. Renaissance Technologies LLC — 0.90%
  6. Worth Venture Partners LLC — 0.60%

Which major investors are selling scPharmaceuticals stock?

In the previous quarter, SCPH stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Ikarian Capital LLC
  3. Worth Venture Partners LLC
  4. Northern Trust Corp
  5. Alyeska Investment Group L.P.
  6. Alyeska Investment Group L.P.

Which major investors are buying scPharmaceuticals stock?

During the previous quarter, SCPH stock was bought by institutional investors including:
  1. BlackRock Inc.
  2. Zacks Investment Management
  3. Virtu Financial LLC
  4. Bank of New York Mellon Corp
  5. JPMorgan Chase & Co.
  6. Wells Fargo & Company MN
  7. Dimensional Fund Advisors LP
During the last year, these company insiders have bought scPharmaceuticals stock:
  1. John H Tucker (CEO)
  2. Andrew J Schwab (Major Shareholder)
  3. Ra Capital Healthcare Fund Lp (Major Shareholder)
  4. Ra Capital Management, LP (Major Shareholder)
World's 2nd Richest Man Is About To Shock The World
Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry...
See what Elon is up to now.